RCM
ADAP

RA Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

RA Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$13.5M Sell
2020
Q3 		$90.4M Sell
2020
Q2 		$131M Buy
2020
Q1 		$34.1M Buy